6665.TWO Healthconn Corp.
- Market cap
- TWD 692M
- P/E
- 31.8x
- P/B
- 0.79x
- ROE
- 0.9%
- Dividend yield
- 4.59%
- Fundamental score
- -
Ratios use the latest price and the fiscal year ending Dec 2025.
Is 6665.TWO undervalued?
Graham number6665.TWO trades 5.8% above its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Healthconn Corp. fundamental analysis
No fundamental analysis for Healthconn Corp. yet.
Healthconn Corp. stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Healthconn Corp.
Healthconn Corp. engages in the provision of health management and prevention solutions in Taiwan and China. The company offers personal and corporate health management, heath promotion, telehealth services, and cancer genetic testing; diagnostic devices and smart testing solutions, such as diagnostic and testing equipment, blood collection tubes and needles, laboratory information systems, automated lab integration, life science research, and cold chain logistics and medica…
Full company profileHealthconn Corp. financial statements
Healthconn Corp. annual financial statements (TWD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||
| Revenue | 460M | 1.11B | 1.73B | 497M | 303M | 1.36B | 1.55B | 1.26B | 1.25B | 1.13B |
| Gross Profit | 279M | 521M | 652M | 276M | 144M | 307M | 303M | 236M | 239M | 204M |
| Operating Income | 179M | 305M | 349M | 133M | 29.2M | 52.3M | 60.9M | 2.95M | 12.3M | 3.15M |
| EBITDA | 210M | 353M | 408M | 174M | 60.9M | 128M | 123M | 66.6M | 90.3M | 70.8M |
| Net Income | 150M | 233M | 271M | 286M | 118M | 37.4M | 25.4M | 2.36M | 19.2M | 8.39M |
| EPS | 3.28 | 5.06 | 5.84 | 6.20 | 2.59 | 0.83 | 0.56 | 0.05 | 0.42 | 0.19 |
| Balance Sheet | ||||||||||
| Total Assets | 803M | 1.23B | 1.40B | 1.43B | 1.40B | 1.77B | 1.66B | 1.54B | 1.52B | 1.49B |
| Total Liabilities | 194M | 408M | 426M | 317M | 413M | 852M | 722M | 622M | 574M | 567M |
| Shareholders' Equity | 609M | 823M | 976M | 1.11B | 991M | 922M | 942M | 916M | 948M | 926M |
| Cash & Short-term Investments | 551M | 515M | 619M | 251M | 254M | 901M | 857M | 805M | 367M | 296M |
| Total Debt | - | 98.0K | 20.0M | 141M | 273M | 509M | 348M | 364M | - | - |
| Cash Flow | ||||||||||
| Operating Cash Flow | 189M | 292M | 251M | 214M | 124M | 85.4M | 167M | 62.8M | 17.3M | 66.8M |
| Capital Expenditure | 43.1M | 32.1M | 34.1M | 12.4M | 2.68M | 74.9M | 70.0M | 14.7M | 20.5M | 23.7M |
| Free Cash Flow | 146M | 260M | 217M | 202M | 122M | 10.5M | 96.8M | 48.1M | -3.15M | 43.1M |
| Ratios | ||||||||||
| ROE | 24.6% | 28.3% | 27.8% | 25.7% | 11.9% | 4.1% | 2.7% | 0.3% | 2.0% | 0.9% |
| ROA | 18.7% | 18.9% | 19.3% | 20.0% | 8.4% | 2.1% | 1.5% | 0.2% | 1.3% | 0.6% |
| Net Profit Margin | 32.6% | 21.0% | 15.7% | 57.6% | 38.9% | 2.7% | 1.6% | 0.2% | 1.5% | 0.7% |
| Debt to Equity | - | 0.00x | 0.02x | 0.13x | 0.28x | 0.55x | 0.37x | 0.40x | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Healthconn Corp. dividends
- Dividend yield
- 4.59%
- Forward dividend
- 0.15 TWD
- Payout ratio
- 378.3%
- Ex-dividend date
- Jul 9, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | TWD 31.8M | 0.70 | 378.3% |
| 2024 | TWD 2.36M | 0.05 | 12.3% |
| 2023 | TWD 20.7M | 0.46 | 877.3% |
| 2022 | TWD 32.0M | 0.71 | 125.8% |
| 2021 | TWD 103M | 2.26 | 274.0% |
| 2020 | TWD 205M | 4.49 | 173.3% |
| 2019 | TWD 151M | 3.27 | 52.7% |
| 2018 | 128M | 2.76 | 47.2% |
| 2017 | - | - | - |
| 2016 | - | - | - |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 1200:1000 on Jul 30, 2019.
Who owns Healthconn Corp.
Ownership data of Healthconn Corp. is not available yet.
Healthconn Corp. company profile
- Company name
- Healthconn Corp.
- Ticker
- 6665.TWO
- Exchange
- Taiwan OTC Exchange
- Sector
- Healthcare
- Industry
- Health Care Providers & Services
- Fiscal year end
- December
- Address
- No. 54, Zhongxiao East Road, Taipei, Taiwan, 100
- Phone
- 886 2 5569 6199
- Website
- healthconn.com
About Healthconn Corp.
Healthconn Corp. engages in the provision of health management and prevention solutions in Taiwan and China. The company offers personal and corporate health management, heath promotion, telehealth services, and cancer genetic testing; diagnostic devices and smart testing solutions, such as diagnostic and testing equipment, blood collection tubes and needles, laboratory information systems, automated lab integration, life science research, and cold chain logistics and medical supply delivery; genetic decoding and precision diagnostics; and clinical bacteriology testing, molecular diagnostics, serology testing, and immunology testing, as well as water quality testing. It also provides diagnostic solutions, including microbiology, total lab automation, molecular biology, life sciences, laboratory information systems, and environment and safety solutions; and warehouse and logistics services. Healthconn Corp. was founded in 2009 and is based in Taipei, Taiwan.
Healthconn Corp. management
3- Bill TsouPresident & Director
- Martin ChiangVice President of Operations
- Ruojing WangAccounting Supervisor